General Information of the Compound
Compound ID |
CP0043633
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4-Methoxy-N-(4-phenyl-thiazol-2-yl)-benzamide
Show/Hide
|
||||||||||||||||||
Synonyms |
(Z)-4-methoxy-N-(4-phenylthiazol-2(3H)-ylidene)benzamide
15850-34-7
4-Methoxy-N-(4-phenyl-thiazol-2-yl)-benzamide
4-methoxy-N-(4-phenyl-1,3-thiazol-2-yl)benzamide
4-methoxy-N-(4-phenylthiazol-2-yl)benzamide
AC1LDKPI
AC1Q49Y1
AKOS001303429
AKOS024573980
BDBM50097431
CHEMBL60156
LUF-5433
MCULE-3254711297
MolPort-001-029-705
MolPort-003-712-982
N-(4-phenylthiazol-2-yl)-4-methoxybenzamide
Oprea1_074264
Oprea1_345855
Oprea1_747035
SCHEMBL2753298
SR-01000394983
SR-01000394983-1
ST042073
STK401912
ZINC1508173
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H14N2O2S
|
||||||||||||||||||
Molecular Weight |
310.378
|
||||||||||||||||||
Canonical SMILES |
COc1ccc(cc1)C(=O)Nc1nc(cs1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H14N2O2S/c1-21-14-9-7-13(8-10-14)16(20)19-17-18-15(11-22-17)12-5-3-2-4-6-12/h2-11H,1H3,(H,18,19,20)
Show/Hide
|
||||||||||||||||||
InChIKey |
FVWGKRAXWKLEHX-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound